The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern US

被引:4
|
作者
Van Gerwen, Olivia T. [1 ]
Yigit, Ibrahim [2 ]
Crockett, Kaylee B. [3 ]
Turan, Bulent [4 ,5 ]
机构
[1] Univ Alabama Birmingham, Div Infect Dis, 703 19th St South,ZRB 218A, Birmingham, AL 35233 USA
[2] TED Univ, Fac Arts & Sci, Dept Psychol, Ankara, Turkey
[3] Univ Alabama Birmingham, Dept Family & Community Med, Birmingham, AL USA
[4] Koc Univ, Coll Social Sci & Humanities, Dept Psychol, Istanbul, Turkey
[5] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
HIV pre-exposure prophylaxis; Adherence; Stigma; PrEP; TENOFOVIR DISOPROXIL FUMARATE; INTERNALIZED STIGMA; PREVENTION; MECHANISMS; INFECTION; EFFICACY; PEOPLE; SCALE; RISK; PREP;
D O I
10.1007/s10461-022-03883-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures of PrEP-related stigma dimensions and PrEP adherence. We administered them to current PrEP users. We hypothesized that PrEP-related stigma would negatively impact PrEP adherence. Questionnaire measures were developed using data from previous qualitative work and existing validated HIV-related stigma measures. The resultant survey was administered to current PrEP users from two Birmingham, Alabama PrEP clinics. Plasma tenofovir disoproxil fumarate levels were collected to measure PrEP adherence. Exploratory factor analyses were performed to determine the factor structure of each PrEP-related stigma dimension (internalized, perceived, experienced, anticipated, disclosure concerns). Separate binary logistic (or linear) regressions were performed to assess associations between PrEP-related stigma dimensions and adherence (treatment adherence self-efficacy, self-reported adherence, and plasma tenofovir levels), adjusting for education, race, and time on PrEP. In 2018, 100 participants completed the survey, with 91 identifying as male and 66 as white. Only internalized stigma was associated with lower self-reported PrEP adherence. Exploratory mediation analyses suggested that the association between all stigma dimensions and self-reported PrEP adherence is mediated by PrEP adherence self-efficacy. No associations were found between any PrEP-related stigma measures and plasma tenofovir levels. Internalized PrEP stigma may reduce PrEP adherence, possibly by reducing PrEP adherence self-efficacy among experienced PrEP users. Further investigation of how stigma dimensions affect PrEP adherence in populations at risk for HIV may shed light on drivers of PrEP underutilization.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [41] Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives
    Nikolopoulos, Georgios K.
    Christaki, Eirini
    Paraskevis, Dimitrios
    Bonovas, Stefanos
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (18) : 2579 - 2591
  • [42] Pre-exposure prophylaxis for HIV: effective and underused
    Hempel, Amanda
    Biondi, Mia J.
    Baril, Jean-Guy
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (34) : E1164 - E1170
  • [43] PrEP: pre-exposure prophylaxis for HIV prevention
    Page, Matthew
    Nicholls, Jane
    TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
  • [44] Pediatric Providers and Hiv Pre-exposure Prophylaxis
    Chenault, Kathryn
    Waddell, Jaylyn
    Tepper, Vicki
    PEDIATRICS, 2018, 141
  • [45] Ethics and Pre-exposure Prophylaxis for HIV Infection
    Sugarman, Jeremy
    Mayer, Kenneth H.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 : S135 - S139
  • [46] Pre-exposure prophylaxis for prevention of HIV infection
    Lee, Joseph Wei En
    Lim, Sze Wern
    Choy, Chiaw Yee
    Wong, Chen Seong
    SINGAPORE MEDICAL JOURNAL, 2023, 64 (10) : 624 - 628
  • [47] Pre-exposure HIV prophylaxis: the world is waiting
    不详
    LANCET, 2012, 379 (9835): : 2402 - 2402
  • [48] Recent advances in pre-exposure prophylaxis for HIV
    Desai, Monica
    Field, Nigel
    Grant, Robert
    McCormack, Sheena
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 : j5011
  • [49] To whom is HIV pre-exposure prophylaxis proposed?
    Ayerdi-Aguirrebengoa, Oskar
    Vera-Garcia, Mar
    Puerta-Lopez, Teresa
    Raposo-Utrilla, Montserrat
    Rodriguez-Martin, Carmen
    Del Romero-Guerrero, Jorge
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (05): : 299 - 302
  • [50] Improving HIV pre-exposure prophylaxis for infants
    Coovadia, Hoosen
    Moodley, Dhayendre
    LANCET, 2016, 387 (10018): : 513 - 514